230 related articles for article (PubMed ID: 17313633)
1. Cost effectiveness of the B type natriuretic peptide, electrocardiography, and portable echocardiography for the assessment of patients from the community with suspected heart failure.
Lim TK; Dwivedi G; Hayat S; Collinson PO; Senior R
Echocardiography; 2007 Mar; 24(3):228-36. PubMed ID: 17313633
[TBL] [Abstract][Full Text] [Related]
2. Value of primary care electrocardiography for the prediction of left ventricular systolic dysfunction in patients with suspected heart failure.
Lim TK; Collinson PO; Celik E; Gaze D; Senior R
Int J Cardiol; 2007 Jan; 115(1):73-4. PubMed ID: 16777249
[TBL] [Abstract][Full Text] [Related]
3. Independent value of echocardiography and N-terminal pro-natriuretic Peptide for the prediction of major outcomes in patients with suspected heart failure.
Lim TK; Hayat SA; Gaze D; Celik E; Collinson P; Senior R
Am J Cardiol; 2007 Sep; 100(5):870-5. PubMed ID: 17719336
[TBL] [Abstract][Full Text] [Related]
4. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
[TBL] [Abstract][Full Text] [Related]
5. Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.
Goode KM; Clark AL; Cleland JG
Int J Cardiol; 2008 Nov; 130(3):426-37. PubMed ID: 18178273
[TBL] [Abstract][Full Text] [Related]
6. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282
[TBL] [Abstract][Full Text] [Related]
7. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?
Galasko GI; Barnes SC; Collinson P; Lahiri A; Senior R
Eur Heart J; 2006 Jan; 27(2):193-200. PubMed ID: 16267076
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of B-type natriuretic peptide for validation of a heart failure register in primary care.
Bhatia GS; Sosin MD; Stubley J; Patel JV; Hughes EA; Gibbs R; Davis RC
BMC Cardiovasc Disord; 2007 Jul; 7():23. PubMed ID: 17663777
[TBL] [Abstract][Full Text] [Related]
10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
11. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of NTproBNP in the emergency management of patients with severe dyspnea and an uncertain heart failure diagnosis].
Pascual Figal DA; Cerdán Sánchez MC; Noguera Velasco JA; Casas Pina T; Muñoz Gimeno L; García Rodríguez R; Ruipérez Abizanda JA; Martínez Hernández P; Valdés Chávarri M
Rev Esp Cardiol; 2005 Oct; 58(10):1155-61. PubMed ID: 16238983
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
Januzzi JL; Chen-Tournoux AA; Moe G
Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
[TBL] [Abstract][Full Text] [Related]
15. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the clinical utility of atrial and B type natriuretic peptide measurement for the diagnosis of systolic dysfunction in a low-risk population.
Galasko G; Collinson PO; Barnes SC; Gaze D; Lahiri A; Senior R
J Clin Pathol; 2007 May; 60(5):570-2. PubMed ID: 17513518
[TBL] [Abstract][Full Text] [Related]
18. What is the most useful and cost-effective strategy to screen for left ventricular systolic dysfunction in clinical practice?
Yamada A; Yamada Y; Okada K
Eur Heart J; 2006 Jun; 27(11):1382-3; author reply 1383. PubMed ID: 16613931
[No Abstract] [Full Text] [Related]
19. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea].
Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P
Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from 'PREDICTOR', a population based-study in central Italy.
Mureddu GF; Tarantini L; Agabiti N; Faggiano P; Masson S; Latini R; Cesaroni G; Miceli M; Forastiere F; Scardovi AB; Uguccioni M; Boccanelli A
Eur J Heart Fail; 2013 Oct; 15(10):1102-12. PubMed ID: 23787717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
